Caris Life Sciences Cash Flow Statement (2024-2026) | CAI

Cash Flow Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Share-based Compensation (Quarter) -8.94M0.72M14.69M-13.03M54.98M-52.79M0.06M
Cash from Operations (Quarter) -69.43M-38.92M-31.34M7.29M62.42M44.78M32.88M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 1.73M1.83M1.91M1.95M7.75M2.46M0.60M2.62M
Amortization of Deferred Charges (Quarter) 1.34M1.38M1.45M1.48M1.39M1.26M1.32M
Depreciation & Amortization (CF) (Quarter) 11.60M10.50M9.07M7.00M6.40M4.90M4.28M5.07M
Change in Working Capital
Change in Receivables (Quarter) -1.90M18.81M-7.91M-29.13M-24.19M91.02M-21.62M
Change in Inventory (Quarter) 3.29M-1.25M-2.06M4.68M8.52M9.61M13.33M
Change in Account Payables (Quarter) 2.43M-5.28M-1.74M-0.19M0.73M12.23M16.37M
Change in Accured Expenses (Quarter) -16.45M14.82M2.58M-21.26M0.89M29.27M-14.98M
Other Working Capital Changes (Quarter) 0.79M-0.77M-2.47M4.74M2.54M0.34M1.55M
Investing Activities
Capital Expenditures (Quarter) -4.17M8.29M-0.04M4.11M7.09M-11.22M-0.15M
Cash from Investing Activities (Quarter) -1.83M-2.29M-2.69M-1.39M-7.09M-5.09M-10.34M
Financing Activities
Other financing activities (Quarter) 0.66M-1.26M1.43M1.19M7.65M518.19M0.92M
Cash from Financing Activities (Quarter) 0.09M0.23M1.28M681.40M-21.10M3.40M0.82M
Additional items
Exchange Rate Effect (Quarter) -0.02M-0.00M0.00M0.09M0.06M-0.03M-0.01M
Change in Cash (Quarter) -71.18M-40.99M-32.74M687.40M34.30M43.06M23.35M
Free Cash Flow (Quarter) -65.26M-47.21M-31.30M3.18M55.33M56.00M33.03M
Net Cash Flow (Quarter) -71.17M-40.98M-32.74M687.30M34.23M43.09M23.36M